Catalyst Biosciences

+$0.12 (+2.95%) As of 6:40 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CBIO and other ETFs, options, and stocks.

About CBIO

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions.

CEO
Nassim Usman
Employees
56
Headquarters
South San Francisco, California
Founded
1997

CBIO Key Statistics

Market Cap
137.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
211.07K
High Today
$4.22
Low Today
$4.12
Open Price
$4.12
Volume
133.37K
52 Week High
$7.55
52 Week Low
$4.03

CBIO Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure